Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Rev. méd. Maule ; 36(2): 42-48, dic. 2021. graf, tab
Artigo em Espanhol | LILACS | ID: biblio-1378497

RESUMO

Infection by SARS-COV-2, was first described in November 2019 in Wuhan, China. First chilean cases where reported in March 2020.Our objective was to identify epidemiological changes in the pediatric population in the emergency service of the Hospital Regional de Talca (HRT). We carried out an observational and retrospective study. The reason and number of consultations in pediatric patients in the emergency room was analyzed during the periods defined as "Pre-pandemic" and "Pandemic". The target population was all consulting patients between 0-15 years of age. We separated the cases according to the reason of consultation. We obtained the data from the HRT statistics department. The number of consultations decreased by 67.6% per month, while the number of patients who consulted in pediatric emergencies for respiratory symptoms decreased by 75.4% per month. Within the pandemic period, 15,101 COVID PCR samples were performed in pediatric patients, with 13.7% positivity. This allows us to see the epidemiological impact that this new disease has had on pediatric patients in the Maule región


Assuntos
Humanos , Criança , Adolescente , Pediatria , Pandemias , COVID-19/epidemiologia , Hospitais Públicos/estatística & dados numéricos , Epidemiologia Descritiva , Estudos Retrospectivos , Serviço Hospitalar de Emergência/estatística & dados numéricos , Monitoramento Epidemiológico , Teste de Ácido Nucleico para COVID-19
2.
Rev. chil. med. intensiv ; 26(4): 209-214, 2011. ilus, tab, graf
Artigo em Espanhol | LILACS | ID: lil-669019

RESUMO

La neumonía grave adquirida en la comunidad (NAC) representa 10 por ciento-30 por ciento del total de esta patología. La morbilidad y la mortalidad son elevadas. Objetivo: Dilucidar factores predictores de mortalidad en NAC. A través de sus historias clínicas, se obtuvieron antecedentes de 121 pacientes (100 por ciento) que ingresaron con este diagnóstico, durante 2005-2010. Resultados: Media de edad de 59,2 +/- 19,1 años, 61,1 por ciento sexo masculino y 79,3 por ciento con comorbilidad; 74,3 por ciento con CURB-65 entre 3 y 5 y 64,4 por ciento con al menos 2 criterios mayores ATS modificados. Media de puntaje de APACHE II de ingreso de 20,3 +/- 7,7 puntos y media de puntaje SOFA de8,5 +/- 3,9 puntos. Mortalidad global del grupo de 31,1 por ciento. Pacientes no fallecidos versus fallecidos con puntaje CURB-65 mayor a 3 en 66,6 por ciento versus 89,4 por ciento, respectivamente (p=0,08), puntaje APACHE II de 18,1 +/- 6,7 versus 25 +/- 7,8 puntos, respectivamente (p<0,0001) y puntaje SOFA de 7,7+/- 4 versus 10 +/- 3,1 puntos, respectivamente (p= 0,003). Mortalidad en relación al ingreso precoz a UCI (antes de 24 horas de evolución) 24,6 por ciento versus 42,2 por ciento cuando fue tardío (p= 0,035). Se observó tendencia a menor mortalidad (26,9 por ciento) en quienes tuvieron cobertura para gérmenes atípicos versus 35,5 por ciento sin cobertura (p= 0,09). El score SOFA y APACHE II en general tienen una buena correlación en relación a mortalidad, sin embargo, la mayor influencia en este punto lo tienen el ingreso precoz a una Unidad de Cuidados Intensivos, los protocolos de reanimación precoz y la cobertura para gérmenes atípicos.


Severe community acquired pneumonia represents 10 –30 percent of this disease. High morbidity and mortality. In this review, we pretend found some predictor factors of mortality in this type of pneumonia. We realize a retrospective study of 121 adult patients admitted at ICU with diagnosis of severe community acquired pneumonia, between 2005-2010. Results: The patients was an average of age of 59,2 +/- 19,1 years, 61,1 percent were male and 79,3 percent with comorbidity; 74,3 percent with CURB – 65 score between 3 – 5 and 64,4 percent with at least 2 major criteria ATS modified. At admission: average of APACHE II score of 20,3 +/- 7,7 points and average of SOFA socre of 8,5 +/- 3,9 points. Global mortality of 31,1 percent. Survivor patients versus patients who died because of the disease, with CURB-65 score up to 3 points in 66,6 percent versus 89,4 percent, respectively (p=0,08), APACHEII score of 18,1 +/- 6,7 versus 25 +/- 7,8 points, respectively (p<0,0001) and SOFA score of 7,7 +/- 4 versus 10 +/- 3,1 points, respectively (p=0,003); 24,6 percent versus 42,2 percent of mortality in early admission to ICU (before 24 hours of evolution) and delayed admission, respectively (p=0,035). Tendence to minor mortality in patients who recived atypical bacteria treatment (26,9 percent versus 35,5 percent, p=0,09). The SOFA and APACHE II score with good correlation with mortality, however, the most important point is the early admission to ICU, early reanimation protocols and atypical bacteria treatment.


Assuntos
Humanos , Masculino , Adulto , Feminino , Pessoa de Meia-Idade , Idoso de 80 Anos ou mais , Infecções Comunitárias Adquiridas/mortalidade , Pneumonia/mortalidade , APACHE , Comorbidade , Cuidados Críticos , Estado Terminal , Previsões , Estudos Retrospectivos , Fatores de Risco , Índice de Gravidade de Doença
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA